EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights

Karolina Mikołajczak, James Chmiel iD, Jerzy Leszek

Cells · 2026

DOI: 10.3390/cells15121111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Karolina Mikołajczak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Internal Medicine, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland. Hauptthemen laut MEDLINE: Alzheimer Disease, Glioblastoma, Neuroinflammatory Diseases, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neuroinflammation is a key feature of both Alzheimer’s disease (AD) and glioblastoma, although it leads to different outcomes in each disorder. In AD, chronic activation of microglia and astrocytes by amyloid-β and tau contributes to neuronal injury and cognitive decline. In glioblastoma, tumor cells exploit inflammatory pathways to create an immunosuppressive microenvironment that supports tumor growth. This review compares the shared and distinct neuroinflammatory mechanisms in AD and glioblastoma and highlights their therapeutic relevance. Materials and Methods: This study was conducted as a narrative review based on a PubMed search performed by three reviewers. English-language articles on AD, glioblastoma, and neuroinflammatory pathways were included, covering original studies, reviews, meta-analyses, and experimental and clinical reports. Keywords included neuroinflammation, microglia, astrocytes, tumor-associated macrophages, inflammasomes, NLRP3, NF-κB, HIF-1α, cytokines, blood–brain barrier, and miRNAs. Due to study heterogeneity, findings were synthesized descriptively.

Results

AD and glioblastoma share major neuroinflammatory mechanisms, including microglial and astrocytic activation, cytokine signaling, inflammasome activity, blood–brain barrier dysfunction, hypoxia-related changes, and miRNA regulation. In AD, these pathways promote chronic inflammation, synaptic loss, and neurodegeneration, with NLRP3, NF-κB, and M1-like microglial polarization playing central roles. In glioblastoma, similar pathways are redirected toward tumor progression through tumor-associated macrophages, reactive astrocytes, angiogenesis, immune evasion, and therapy resistance. Key overlapping mediators include IL-1β, TNF-α, NF-κB, HIF-1α, GSK-3β, and selected miRNAs.

Conclusions

AD and glioblastoma are connected by common neuroinflammatory pathways, but these processes result in neurodegeneration in AD and tumor support in glioblastoma. Understanding these shared and divergent mechanisms may guide the development of biomarkers and targeted therapies focused on microglia, inflammasomes, cytokines, and immune reprogramming in both diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGlioblastomaNeuroinflammatory DiseasesBrain NeoplasmsHumansAnimalsMicrogliaInflammasomesInflammationCytokinesBlood-Brain Barrier

Stichwörter der Autor:innen

Alzheimer’s diseaseglioblastomagliomaneuroinflammation

Substanzen

InflammasomesCytokines

Autor:innen und Institutionen

  • Department of Rheumatology and Internal Medicine, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland.
  • Institute of Physical Culture Sciences, Faculty of Physical Culture and Health, University of Szczecin, Al. Piastów 40B Block 6, 71-065 Szczecin, Poland.
  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland.

ORCID-Profile: James Chmiel

Zitieren

APA

Mikołajczak, K., Chmiel, J., & Leszek, J. (2026). Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights. Cells. https://doi.org/10.3390/cells15121111

Vancouver

Mikołajczak K, Chmiel J, Leszek J. Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights. Cells. 2026. doi:10.3390/cells15121111

BibTeX
@article{Mikoajczak2026,
  author = {Mikołajczak, Karolina and Chmiel, James and Leszek, Jerzy},
  title = {Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15121111}
}
Kostenlos starten →